Understanding and Treating Various Skin Types: The Baumann Skin Type Indicator

Dermatologic Clinics

Volumn 26, Issue 3, 2008, Pages 359-373

  Baumann, Leslie ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Antioxidants; Aquaporin 3; Inhibitors; Natural mosturizing factor; Protease activated receptor 2; Telomeres; Tyrosinase; Xerosis

Indexed keywords

ANTIOXIDANT; AQUAPORIN 3; COLLAGEN; EMOLLIENT AGENT; GLYCEROL; HUMECTANT; HYALURONIC ACID; HYDROXYACID; LACTIC ACID; POLYPEPTIDE; TYROSINE; UREA;

ACNE; ALLERGY; BAUMANN SKIN TYPE INDICATOR; CLASSIFICATION; COSMETIC INDUSTRY; CUTANEOUS PARAMETERS; DRY SKIN; HUMAN; HYDRATION; OILY SKIN; PRIORITY JOURNAL; REVIEW; ROSACEA; SKIN CARE; SKIN MANIFESTATION; SKIN PIGMENTATION; SKIN SENSITIVITY; TELOMERE; WRINKLE; XEROSIS;

BEAUTY CULTURE; HUMANS; SKIN; SKIN AGING; SKIN CARE; SKIN DISEASES; SKIN PIGMENTATION;

EID: 44849100841     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2008.03.007     Document Type: Review

References (98)

1. Baumann L. The skin type solution (2006), Bantam Dell, New York
2. Chernosky M.E. Clinical aspects of dry skin. J Soc Cosmet Chem 27 (1976) 365-376
3. Elias P.M. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125 2 (2005) 183-200
4. Wildnauer R.H., Bothwell J.W., and Douglass A.B. Stratum corneum biomechanical properties. I. Influence of relative humidity on normal and extracted human stratum corneum. J Invest Dermatol 56 1 (1971) 72-78
5. Orth D., and Appa Y. Glycerine: a natural ingredient for moisturizing skin. In: Loden M., and Maibach H. (Eds). Dry skin and moisturizers (2000), CRC Press, Boca Raton (FL) 214
6. Rawlings A., Hope J., Rogers J., et al. Skin dryness-what is it?. [abstract]. J Invest Dermatol 100 (1993) 510
7. Ekholm I.E., Brattsand M., and Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J Invest Dermatol 114 1 (2000) 56-63
8. Elias P.M. The epidermal permeability barrier: from the early days at Harvard to emerging concepts. J Invest Dermatol 122 2 (2004) xxxvi-xxxix
9. Scott I.R., and Harding C.R. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115 1 (1986) 84-92
10. Sato J., Denda M., Chang S., et al. Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J Invest Dermatol 119 4 (2002) 900-904
11. Wang F., Feng X.C., Li Y.M., et al. Aquaporins as potential drug targets. Acta Pharmacol Sin 27 4 (2006) 395-401
12. Sougrat R., Morand M., Gondran C., et al. Functional expression of AQP3 in human skin epidermis and reconstructed epidermis. J Invest Dermatol 118 4 (2002) 678-685
13. Takenouchi M., Suzuki H., and Tagami H. Hydration characteristics of pathologic stratum corneum-evaluation of bound water. J Invest Dermatol 87 5 (1986) 574-576
14. Warner R.R., Bush R.D., and Ruebusch N.A. Corneocytes undergo systematic changes in element concentrations across the human inner stratum corneum. J Invest Dermatol 104 4 (1995) 530-536
15. Warner R.R., Myers M.C., and Taylor D.A. Electron probe analysis of human skin: element concentration profiles. J Invest Dermatol 90 1 (1988) 78-85
16. Warner R.R., Myers M.C., and Taylor D.A. Electron probe analysis of human skin: determination of the water concentration profile. J Invest Dermatol 90 2 (1988) 218-224
17. Ma T., Hara M., Sougrat R., et al. Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3. J Biol Chem 277 19 (2002) 17147-17153
18. Yang B., and Verkman A.S. Water and glycerol permeabilities of aquaporins 1-5 and MIP determined quantitatively by expression of epitope-tagged constructs in Xenopus oocytes. J Biol Chem 272 26 (1997) 16140-16146
19. Dumas M., Gondran C., Barre P., et al. Effect of an Ajuga turkestanica extract on aquaporin 3 expression, water flux, differentiation and barrier parameters of the human epidermis. Eur J Dermatol 12 6 (2002) XXV-XXVI
20. Thiboutot D. Regulation of human sebaceous glands. J Invest Dermatol 123 1 (2004) 1-12
21. Clarys P., and Barel A. Quantitative evaluation of skin surface lipids. Clin Dermatol 13 4 (1995) 307-321
22. Thody A.J., and Shuster S. Control and function of sebaceous glands. Physiol Rev 69 2 (1989) 383-416
23. Elias P.M., Fritsch P.O., Lampe M., et al. Retinoid effects on epidermal structure, differentiation, and permeability. Lab Invest 44 6 (1981) 531-540
24. Gomez E.C. Differential effect of 13-cis-retinoic acid and an aromatic retinoid (Ro 10-9359) on the sebaceous glands of the hamster flank organ. J Invest Dermatol 76 1 (1981) 68-69
25. Geiger J.M. Retinoids and sebaceous gland activity. Dermatology 191 4 (1995) 305-310
26. Mathers W.D., and Lane J.A. Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol 438 (1998) 349-360
27. Tiffany J.M. The role of meibomian secretion in the tears. Trans Ophthalmol Soc U K 104 Pt 4 (1985) 396-401
28. Fluhr J.W., Mao-Qiang M., Brown B.E., et al. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol 120 5 (2003) 728-737
29. Fluhr J.W., Gloor M., Lehmann L., et al. Glycerol accelerates recovery of barrier function in vivo. Acta Derm Venereol 79 6 (1999) 418-421
30. Pochi P.E., Strauss J.S., and Downing D.T. Age-related changes in sebaceous gland activity. J Invest Dermatol 73 1 (1979) 108-111
31. Walton S., Wyatt E.H., and Cunliffe W.J. Genetic control of sebum excretion and acne-a twin study. Br J Dermatol 118 3 (1988) 393-396
32. De Pedrini P., Rapisarda R., and Spano G. The effect of ketoconazole on sebum secretion in patients suffering from acne and seborrhoea. Int J Tissue React 10 2 (1988) 111-113
33. Goldstein J.A., Socha-Szott A., Thomsen R.J., et al. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. J Am Acad Dermatol 6 Suppl 4 Pt 2 (1982) 760-765
34. Vogel C.A., Balkrishnan R., Fleischer A.B., et al. Over-the-counter topical skin care products-a common component of skin disease management. Cutis 74 1 (2004) 55-67
35. Morrison D. Petrolatum. In: Loden M., and Maibach H. (Eds). Dry skin and moisturizers (2000), CRC Press, Boca Raton (FL) 251
36. Spruit D. The interference of some substances with the water vapour loss of human skin. Dermatologica 142 2 (1971) 89-92
37. Draelos Z. Moisturizers. In: Draelos Z. (Ed). Atlas of cosmetic dermatology (2000), Churchill Livingstone, New York p. 83
38. Kraft J.N., and Lynde C.W. Moisturizers: what they are and a practical approach to product selection. Skin Therapy Lett 10 5 (2005) 1-8
39. Kligman A.M. The myth of lanolin allergy. Contact Dermatitis 39 (1998) 103-107
40. Wehr R.F., and Krochmal L. Considerations in selecting a moisturizer. Cutis 39 6 (1987) 512-515
41. Hannuksela M. Glycols. In: Loden M., and Maibach H. (Eds). Dry skin and moisturizers (2000), CRC Press, Boca Raton (FL) 413-415
42. Idson B. Dry skin: moisturizing and emolliency. Cosmetics & Toiletries 107 (1992) 69-78
43. Del Rosso J.Q. Cosmeceutical moisturizers. In: Draelos Z.D. (Ed). Procedures in cosmetic dermatology series: cosmeceuticals. 1st edition (2005), Elsevier, Philadelphia 97-102
44. In: Mitsui T. (Ed). New cosmetic science (1997), Elsevier, New York 134
45. Orth D., and Appa Y. Glycerine: a natural ingredient for moisturizing skin. In: Loden M., and Maibach H. (Eds). Dry skin and moisturizers (2000), CRC Press, Boca Raton (FL) 217
46. Orth D., Appa Y., Contard E., et al. Effect of high glycerin therapeutic moisturizers on the ultrastructure of the stratum corneum. Poster presentation at the 53rd annual meeting of the American Academy of Dermatology. New Orleans (LA) (February 1995)
47. Harding C., Bartolone J., and Rawlings A. Effects of natural moisturizing factor and lactic acid isomers on skin function. In: Loden M., and Maibach H. (Eds). Dry skin and moisturizers (2000), CRC Press, Boca Raton (FL) 229
48. Kligman A.M. Dermatologic uses of urea. Acta Derm Venereol 37 (1957) 155-159
49. Wohlrab W. The influence of urea on the penetration kinetics of topically applied corticosteroids. Acta Derm Venereol 64 (1984) 233-238
50. Wohlrab W. Effect of urea on the penetration kinetics of vitamin A acid in human skin. Z Hautkr 65 (1990) 803-805
51. The cosmetic ingredient review (CIR) expert panel. Final report of the safety assessment of urea. Int J Toxicol 24 Suppl 3 (2005) 1-56
52. Serup J. A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme. Acta Derm Venereol Suppl (Stockh) 177 (1992) 34-43
53. Van Scott E.J., and Yu R.J. Control of keratinization with alpha hydroxy acids and related compounds. I. Topical treatment of ichthyotic disorders. Arch Dermatol 110 (1974) 586-590
54. Perricone N.V., and Dinardo J.C. Photoprotective and antiinflammatory effects of topical glycolic acid. Dermatol Surg 22 (1996) 435-437
55. Draelos Z.D. Rediscovering the cutaneous benefits of salicylic acid. Cosmetic Dermatology 10 Suppl 4 (1997) 4-5
56. Van Scott E.J., and Yu R. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 11 (1984) 867-879
57. Berardesca E., Distante F., Vignoli G.P., et al. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol 137 (1997) 934-938
58. Stern E. Topical application of lactic acid in the treatment and prevention of certain disorders of the skin. Urol Cutaneous Rev 50 (1943) 106-107
59. Rawlings A.V., Davies V., Carlomusto M., et al. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res 288 (1996) 383-390
60. Harding C.R., Bartolone J., and Rawlings A.V. Effectof natural mosturizing factor and lactic acid isomers on skin function. In: Loden M., and Maibach H. (Eds). Dry skin and mosturizers (2000), CRC Press, Boca Raton (FL) 236
61. Stiller M.J., Bartolone J., Stern R., et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Arch Dermatol 132 (1996) 631-636
62. Draelos Z. Moisturizers. In: Draelos Z. (Ed). Atlas of cosmetic dermatology (2000), Churchill Livingstone, New York p. 85
63. Gonzalo M.A., de Argila D., Garcia J.M., et al. Allergic contact dermatitis to propylene glycol. Allergy 54 (1999) 82-83
64. Baumann L.S., and Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg 25 (1999) 311-315
65. Draelos Z.D. Cosmetic selection in the sensitive-skin patient. Dermatol Ther 14 (2001) 194-199
66. National rosacea society website. Available at:. http://www.rosacea.org/index.php Accessed October 12, 2007
67. Rothenberg M.E., and Hogan S.P. The eosinophil. Annu Rev Immunol 24 (2006) 147-174
68. Shakoory B., Fitzgerald S.M., Lee S.A., et al. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res 24 5 (2004) 271-281
69. Brown D.J., and Dattner A.M. Phytotherapeutic approaches to common dermatologic conditions. Arch Dermatol. 134 11 (1998) 1401-1404
70. Basketter D.A., and Griffiths H.A. A study of the relationship between susceptibility to skin stinging and skin irritation. Contact Dermatitis. 29 4 (1993) 185-188
71. Lonne-Rahm S.B., Fischer T., and Berg M. Stinging and rosacea. Acta Derm Venereol. 79 6 (1999) 460-461
72. Orton D.I., and Wilkinson J.D. Cosmetic allergy: incidence, diagnosis, and management. Am J Clin Dermatol 5 5 (2004) 327-337
73. Mehta S.S., and Reddy B.S. Cosmetic dermatitis current perspectives. Int J Dermatol 42 7 (2003) 533-542
74. Jovanovic M., Poljacki M., Duran V., et al. Contact allergy to Compositae plants in patients with atopic dermatitis. Med Pregl 57 5-6 (2004) 209-218
75. In: Freedberg I.M., Eisen A.Z., Wolff K., et al. (Eds). Fitzpatrick's dermatology in general medicine. 5th edition (1999), McGraw-Hill, New York 996
76. Wakamatsu K., Kavanagh R., Kadekaro A.L., et al. Diversity of pigmentation in cultured human melanocytes is due to differences in the type as well as quantity of melanin. Pigment Cell Res 19 2 (2006) 154-162
77. Szabo G., Gerald A.B., Pathak M.A., et al. Racial differences in the fate of melanosomes in human epidermis. Nature 222 198 (1969) 1081-1082
78. Hermanns J.F., Petit L., Martalo O., et al. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. Dermatology 201 2 (2000) 118-122
79. Briganti S., Ottaviani M., and Picardo M. Chemical, pharmologic, and physical agents causing hypomelanosis. In: Nordlund J.J. (Ed). The pigmentary system (2006), Oxford University Press, New York 678
80. Seiberg M., Paine C., Sharlow E., et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 115 2 (2000) 162-167
81. Paine C., Sharlow E., Liebel F., et al. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol 116 4 (2001) 587-595
82. Hakozaki T., Minwalla L., Zhuang J., et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 147 1 (2002) 20-31
83. Boukamp P. Ageing mechanisms: the role of telomere loss. Clin Exp Dermatol 26 7 (2001) 562-565
84. Boukamp P. Skin aging: a role for telomerase and telomere dynamics?. Curr Mol Med 5 2 (2005) 171-177
85. Kosmadaki M.G., and Gilchrest B.A. The role of telomeres in skin aging/photoaging. Micron 35 3 (2004) 155-159
86. Kappes U.P., Luo D., Potter M., et al. Short- and long-wave UV light (UVB and UVA) induce similar mutations in human skin cells. J Invest Dermatol 126 3 (2006) 667-675
87. Marrot L., Beladi J.P., and Meunier J.R. Importance of UVA photoprotection as shown by genotoxic related endpoints: DNA damage and p53 status. Mutat Res 571 1-2 (2005) 175-184
88. Baumann L. How to prevent photoaging?. J Invest Dermatol. 125 4 (2005) xii-xiii
89. Varani J., Warner R.L., Gharaee-Kermani M., et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 114 3 (2000) 480-486
90. Nusgens B.V., Humbert P., Rougier A., et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol 116 6 (2001) 853-859
91. Kockaert M., and Neumann M. Systemic and topical drugs for aging skin. J Drugs Dermatol. 2 4 (2003) 435-441
92. Margelin D., Medaisko C., Lombard D., et al. Hyaluronic acid and dermatan sulfate are selectively stimulated by retinoic acid in irradiated and nonirradiated hairless mouse skin. J Invest Dermatol 106 3 (1996) 505-509
93. Tajima S., Hayashi A., and Suzuki T. Elastin expression is up-regulated by retinoic acid but not by retinol in chick embryonic skin fibroblasts. J Dermatol Sci 15 3 (1997) 166-172
94. Matheson A.J., and Perry C.M. Glucosamine: a review of its use in the management of osteoarthritis. Drugs Aging 20 14 (2003) 1041-1060
95. Fitzpatrick R.E. Endogenous growth factors as cosmeceuticals. Dermatol Surg 31 7 Pt 2 (2005) 827-831 [discussion: 831]
96. Fisher G.J., and Voorhees J.J. Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc 3 1 (1998) 61-68
97. Kang S., Chung J.H., Lee J.H., et al. Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo. J Invest Dermatol 120 5 (2003) 835-841
98. Ostler E.L., Wallis C.V., Aboalchamat B., et al. Telomerase and the cellular lifespan: implications of the aging process. J Pediatr Endocrinol Metab 13 Suppl 6 (2000) 1467-1476